DocDollars

Tanabe Pharma America, Inc.

NJ · United States · Reporting entity ID 100000191780

Total reported 2019–2025
$24.9M
#278 of 2,960 reporting companies — 0% of all reported industry payments
$1.77M in general payments across 17,405 records, plus $23.2M in research funding across 2,904 records.

How it breaks down

General payments $1,766,614
Research funding $23,169,907

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Tanabe Pharma America, Inc. reported $24.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #278 of 2,960 reporting companies. 93% of that was research funding and 7% general payments such as consulting, speaking, food and travel. 17,405 general payment records and 2,904 research records were filed.

Common questions about Tanabe Pharma America, Inc.

How much has Tanabe Pharma America, Inc. paid US doctors?

Tanabe Pharma America, Inc. reported $24,936,520 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,766,614 in general payments, $23,169,907 in research funding.

How does Tanabe Pharma America, Inc. rank among drug and device companies?

It ranks #278 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Tanabe Pharma America, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.